HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Is a reduced intensity treatment with Rituximab effective in acquired haemophilia A?

AuthorsG Castaman, A Tosetto
JournalHaemophilia : the official journal of the World Federation of Hemophilia (Haemophilia) Vol. 17 Issue 5 Pg. 817-8 (Sep 2011) ISSN: 1365-2516 [Electronic] England
PMID21371198 (Publication Type: Case Reports, Letter)
Chemical References
  • Antibodies, Monoclonal, Murine-Derived
  • Blood Coagulation Factor Inhibitors
  • Immunologic Factors
  • Rituximab
Topics
  • Aged
  • Antibodies, Monoclonal, Murine-Derived (administration & dosage)
  • Blood Coagulation Factor Inhibitors (blood)
  • Hemophilia A (drug therapy, immunology)
  • Humans
  • Immunologic Factors (administration & dosage)
  • Male
  • Rituximab
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: